USPTO serial 99340293
BLYSVIA
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- UKAOMA, ULOMA JANET
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with BLYSVIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anthony E. Bennett
Anthony E. Bennett Hoffmann & Baron, LLP6900 Jericho TurnpikeSyosset, NY 11791United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Transdermal patches for use in the treatment of food allergies; adhesive skin patches for medical use for use in the treatment of food allergies; transdermal and adhesive skin patches for treating, alleviating and preventing the development or progression of allergies and immunological disorders; transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals and medical preparations; patches or epicutaneous systems, namely, patches for cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders; adhesive patches or adhesive epicutaneous systems, namely, patches, for cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders; occlusive patches or occlusive epicutaneous systems, namely, patches, for cutaneous and epicutaneous administration of powdered medical and pharmaceutical substances for treating allergies and immunological disorders; patches or epicutaneous systems, namely, patches, containing a powdered preparation for medical and pharmaceutical use for treating allergies and immunological disorders; patches or epicutaneous systems, namely, patches, for use in the treatment of allergies and immunological disorders; patches or epicutaneous systems, namely, patches, featuring allergens or antigens for treating allergies and immunological disorders; allergy medication; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; parts and fittings for the aforesaid goods | ACTIVE | — |
| 010 | Nonmedicated skin patches sold without medication for medical training purposes; nonmedicated skin patches sold without medication for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations; parts and fittings for all the aforesaid goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 2, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 6, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 6, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 6, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 6, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 18, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 15, 2025 | NWAP | NEW APPLICATION ENTERED | — |